Skip to search formSkip to main contentSkip to account menu

Remaxol

National Institutes of Health

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2017
2017
Despite the long period of studying non-alcoholic fatty liver disease, its timely diagnosis, prevention and treatment remains one… 
2016
2016
AIM To investigate the effect of Remaxol on the efficiency of standard treatment in patients with infiltrative pulmonary… 
2015
2015
The objective of the research was to study the effectiveness of including drug remaxol in the scheme of therapy for patients with… 
2013
2013
Experiments on male albino outbred rats investigated the hepatoprotective activity of remaxol and ademethionine in liver damage… 
2012
2012
  • S. Ds
  • 2012
  • Corpus ID: 68075844
Aim. To comparatively evaluate the hepatoprotective activity of reamberine, remaxol, and exogenous ademethionine and a risk for… 
2012
2012
AIM To identify and determine the mechanisms of an association between arterial hypertension (AH) and proatherogenic systemic… 
2012
2012
To improve the treatment of hepatotoxic responses to antituberculosis polychemotherapy, the impact of remaxol on the biochemical… 
2011
2011
The hepatoprotective activity of remaxol, reamberin and ademethionine was studied on a model of the liver injury induced by… 
2011
2010
2010
: Remaxol is a new infusion hepatoprotector that contains succinic acid, inosine, methionine and methylglucamine. The…